CO-1.01与吉西他滨一线治疗转移性胰腺腺癌的II期随机开放标签多中心研究数据集

资源简介

CO-1.01与吉西他滨一线治疗转移性胰腺腺癌的II期随机开放标签多中心研究数据集

【数据集背景】

本数据集源站标题为《A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 With Gemcitabine as First-Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma》。源站首次发布：2019。

【数据内容】

源站原始描述：The purpose of this study is to determine whether CO-1.01 is safe and effective in the treatment of patients with metastatic pancreatic cancer and low hENT1 expression compared with gemcitabine

中文译文（机器翻译，仅供快速理解，请以原文为准）：本研究的目的是确定，与吉西他滨相比，CO-1.01 在治疗 hENT1 低表达的转移性胰腺癌患者中是否安全有效。

【获取与许可】

源站页面：https://search.vivli.org/doiLanding/studies/00003908/isLanding

使用许可：Study data may be accessed by completing a request form at https://vivli.org. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembers/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreemen。